Page results
-
UCLH will play a vital role in a new respiratory virus study.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
File results
-
FOI/2022/0266 - Drug Patient Level Contract Monitoring (DrPLCM)/ SACT cancer report
-
FOI/2023/0374 - Stillbirths, neonatal deaths, maternal deaths at Trust from 2018 - 2022
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0386 - Sickle Cell staffing and patients
-
FOI/2023/0392 - Treatment/ medication for biologic medicines in gastroenterology
-
FOI/2023/0394 - Business continuity plans for telecommunications system/ bleep/ switchboard